Mrs Stacie Kendra Felton, PLMHP | |
445 E 1st St, Fremont, NE 68025-5617 | |
(402) 721-7169 | |
(402) 721-7189 |
Full Name | Mrs Stacie Kendra Felton |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 445 E 1st St, Fremont, Nebraska |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235147679 | NPI | - | NPPES |
10025115400 | Medicaid | NE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | 7859 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Stacie Kendra Felton, PLMHP 445 E 1st St, Fremont, NE 68025-5617 Ph: (402) 721-7169 | Mrs Stacie Kendra Felton, PLMHP 445 E 1st St, Fremont, NE 68025-5617 Ph: (402) 721-7169 |
News Archive
The coronavirus disease (COVID-19) has spread to 184 countries and territories. Currently, there is no vaccine available for COVID-19 disease, or SARS-CoV-2 infection. However, scientists around the world are racing to find ways to block the virus.
A team led by Ludwig and Memorial Sloan Kettering (MSK) researchers has published a landmark study on the genetic basis of response to a powerful cancer therapy known as immune checkpoint blockade.
Halozyme Therapeutics, Inc. today announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®.
Autism spectrum disorders (ASD), especially without an accompanying intellectual disability, were associated with greater risk for depression in young adulthood compared with the general population and siblings without ASD.
Huixin He, associate professor, nanoscale chemistry at Rutgers University, Newark, and Tamara Minko, professor at the Rutgers Ernest Mario School of Pharmacy, have developed a nanotechnology approach that potentially could eliminate the problems of side effects and drug resistance in the treatment of cancer. Under traditional chemotherapy, cancer cells, like bacteria, can develop resistance to drug therapy, leading to a relapse of the disease.
› Verified 8 days ago
Kaitlyn Ann Smith, Counselor Medicare: Not Enrolled in Medicare Practice Location: 230 E 22nd St Ste 4, Fremont, NE 68025 Phone: 402-727-1592 | |
Ms. Alicia Michelle Falcone, MS, PLMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 424 W 23rd St Ste D, Fremont, NE 68025 Phone: 402-658-0654 Fax: 402-727-4288 | |
Marianne Hodson, LIMHP, MSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 450 E 23rd St, Fremont, NE 68025 Phone: 402-941-7861 | |
Tracy Ann Muller, MA LIMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 2170 N Platte Ave, Fremont, NE 68025 Phone: 402-720-7206 | |
Janette Bentley, LMHP Counselor Medicare: Medicare Enrolled Practice Location: 511 N D St, Fremont, NE 68025 Phone: 402-651-0684 Fax: 402-727-0779 | |
Meaghan Noel Delaney, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2320 N Colorado Ave, Fremont, NE 68025 Phone: 402-721-7710 | |
Mr. Kael Gerhardt Busing, MSC, PLMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 230 E 22nd St, Fremont, NE 68025 Phone: 402-727-1592 |